ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,726Medicare Part D Prescriptions Filled, Including Refills

Rank: 360 out of 2343

$654K Total Retail Price of All Prescriptions

Rank: 381 out of 2343

391 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

23% of this provider’s 391 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 9,488 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 415 354 1 1
METOPROLOL TARTRATE 402 351 2 7
FUROSEMIDE 355 272 3 6
LEVOTHYROXINE SODIUM 347 307 4 2
WARFARIN SODIUM 302 227 5 8
AMLODIPINE BESYLATE 302 243 5 5
LISINOPRIL 295 262 7 3
OMEPRAZOLE 262 205 8 4
MIRTAZAPINE 241 226 9 41
RISPERIDONE 230 205 10 61
DONEPEZIL HCL 219 219 11 21
NAMENDA 202 202 12 36
CITALOPRAM HBR 188 166 13 17
SERTRALINE HCL 170 113 14 20
TRAZODONE HCL 162 144 15 53
POTASSIUM CHLORIDE 151 123 16 18
TRAMADOL HCL 141 103 17 25
LOSARTAN POTASSIUM 138 113 18 19
GABAPENTIN 136 120 19 16
METFORMIN HCL 136 101 19 9
TAMSULOSIN HCL 136 115 19 29
METOPROLOL SUCCINATE 127 98 22 14
OXYCODONE-ACETAMINOPHEN 125 84 S2 23 49
LANTUS 123 99 24 51
LEVETIRACETAM 114 75 25 104
ZOLPIDEM TARTRATE 113 77 26 24
CARVEDILOL 111 93 27 27
FENTANYL 105 78 S2 28 69
HYDROCHLOROTHIAZIDE 105 85 28 11
PANTOPRAZOLE SODIUM 102 81 30 22
PREDNISONE 97 95 31 37
PRAVASTATIN SODIUM 97 84 31 15
DIVALPROEX SODIUM 93 58 33 105
LOSARTAN-HYDROCHLOROTHIAZIDE 89 71 34 64
CLOPIDOGREL 87 86 35 26
ATORVASTATIN CALCIUM 85 83 36 10
SANTYL 84 60 37 195
ENDOCET 82 53 S2 38 97
SPIRIVA 81 59 39 48
QUETIAPINE FUMARATE 71 52 40 77
IPRATROPIUM-ALBUTEROL 70 69 41 99
FINASTERIDE 69 69 42 80
JANUVIA 68 30 43 50
CYMBALTA 65 37 44 74
FAMOTIDINE 65 64 44 60
ABILIFY 64 57 46 159
CIPROFLOXACIN HCL 64 55 46 72
DIGOXIN 63 63 48 35
ESCITALOPRAM OXALATE 62 53 49 55
METOCLOPRAMIDE HCL 62 33 49 168
ALENDRONATE SODIUM 61 61 51 28
ISOSORBIDE MONONITRATE ER 61 48 51 32
POLYETHYLENE GLYCOL 3350 61 45 51 54
PLAVIX 58 52 54 38
MORPHINE SULFATE ER 58 49 S2 54 142
ADVAIR DISKUS 57 52 56 34
GLYBURIDE 56 42 R 57 62
DIOVAN 55 42 58 23
ATENOLOL 55 49 58 12
NOVOLOG 54 37 60 110
HYDRALAZINE HCL 54 44 60 92
ENOXAPARIN SODIUM 53 0 62 203
LOVASTATIN 53 31 62 47
LACTULOSE 52 33 64 139
CELEBREX 52 46 64 71
ALLOPURINOL 51 32 66 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.